Back
Bolt Biotherapeutics Quote, Financials, Valuation and Earnings
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Sell
40
BOLT
Bolt Biotherapeutics
Last Price:
0.64
Seasonality Move:
-18.53%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!Bolt Biotherapeutics Price Quote
$0.64
-0.01 (-1.74%)
(Updated: November 9, 2024 at 5:15 AM ET)
Bolt Biotherapeutics Key Stats
Sell
40
Bolt Biotherapeutics (BOLT)
is a Sell
Day range:
$0.63 - $0.67
52-week range:
$0.55 - $1.56
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.21
P/B ratio:
0.29%
Volume:
116.1K
Avg. volume:
112.1K
1-year change:
-35.09%
Market cap:
$24.8M
Revenue:
$7.9M
EPS:
$-1.74
How Much Does Bolt Biotherapeutics Make?
-
How Much Are Bolt Biotherapeutics's Sales Annually?
BOLT Revenues are $7.9M -
How Much Profit Does Bolt Biotherapeutics's Make A Year?
BOLT net income is -$69.2M
Is Bolt Biotherapeutics Growing As A Company?
-
What Is Bolt Biotherapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.11% -
What Is Bolt Biotherapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Bolt Biotherapeutics Stock Price Performance
-
Did Bolt Biotherapeutics Stock Go Up Last Month?
Bolt Biotherapeutics share price went up by 1.26% last month -
Did BOLT's Share Price Rise Over The Last Year?
BOLT share price fell by -35.09% over the past 1 year
What Is Bolt Biotherapeutics 52-Week High & Low?
-
What Is Bolt Biotherapeutics’s 52-Week High Share Price?
Bolt Biotherapeutics has traded as high as $1.56 over the past 52 weeks -
What Is Bolt Biotherapeutics’s 52-Week Low Share Price?
Bolt Biotherapeutics has traded as low as $0.55 over the past 52 weeks
Bolt Biotherapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Bolt Biotherapeutics?
-
How Much Debt Does Bolt Biotherapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Bolt Biotherapeutics Have?
Cash and short term investments quarterly total is $73.7M -
What Is Bolt Biotherapeutics’s Book Value Per Share?
Book value per share is 2.24
Is Bolt Biotherapeutics Cash Flow Positive?
-
What Is BOLT Cash Flow From Operations?
Cash flow from operations (TTM) is -$63.9M -
What Is Bolt Biotherapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $0 -
What Is Bolt Biotherapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $56.7M
Bolt Biotherapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
BOLT return on invested capital is -57.72% -
What Is Bolt Biotherapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -41.72% -
What Is BOLT Return On Equity?
ROE is a measure of profitability and is -57.72%
Bolt Biotherapeutics Earnings Date & Stock Price
-
What Is Bolt Biotherapeutics's Stock Price Today?
A single share of BOLT can be purchased today for 0.65 -
What Is Bolt Biotherapeutics’s Stock Symbol?
Bolt Biotherapeutics trades on the nasdaq under the ticker symbol: BOLT -
When Is Bolt Biotherapeutics’s Next Earnings Date?
The next quarterly earnings date for Bolt Biotherapeutics is scheduled on May 14, 2025 -
When Is BOLT's next ex-dividend date?
Bolt Biotherapeutics's next ex-dividend date is August 29, 2014 -
How To Buy Bolt Biotherapeutics Stock?
You can buy Bolt Biotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Bolt Biotherapeutics Competitors
-
Who Are Bolt Biotherapeutics's Competitors?
Below is a list of companies who compete with Bolt Biotherapeutics or are related in some way:
Bolt Biotherapeutics Dividend Yield
-
What Is BOLT Dividend Yield?
Bolt Biotherapeutics’s dividend yield currently is 0% -
What Is Bolt Biotherapeutics’s Payout Ratio?
Bolt Biotherapeutics’s payout ratio is 0% -
When Did Bolt Biotherapeutics Last Pay A Dividend?
The latest dividend pay date is November 10, 2024 -
What Is Bolt Biotherapeutics’s Dividend Per Share?
Bolt Biotherapeutics pays a dividend of $0.00 per share
Bolt Biotherapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 4.55% |
| Revenue: | -11.03% | 43.02% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 4 |
| Sell Recommendations: | 0 |
| Price Target: | 1.75 |
| Upside from Last Price: | 169.6% |